Enterohemorrhagic Escherichia coli serotype O157:H7 is a food borne enteric bacterial pathogen that causes significant morbidity and mortality in both developing and industrialized nations. E. coli O157:H7 infection of host epithelial cells inhibits the interferon gamma pro-inflammatory signaling pathway, which is important for host defense against microbial pathogens, through the inhibition of Stat-1 tyrosine phosphorylation. The aim of this study was to determine which bacterial factors are involved in the inhibition of Stat-1 tyrosine phosphorylation. Human epithelial cells were challenged with either live bacteria or bacterial-derived culture supernatants, stimulated with interferon-gamma, and epithelial cell protein extracts were then analyzed by immunoblotting. The results show that Stat-1 tyrosine phosphorylation was inhibited by E. coli O157:H7 secreted proteins. Using sequential anion exchange and size exclusion chromatography, YodA was identified, but not confirmed to mediate subversion of the Stat-1 signaling pathway using isogenic mutants. We conclude that E. coli O157:H7 subverts Stat-1 tyrosine phosphorylation in response to interferon-gamma through a still as yet unidentified secreted bacterial protein.
References
[1]
DuPont HL (2009) Clinical practice. Bacterial diarrhea. N Engl J Med 361: 1560–1569.
Jones RM, Neish AS (2011) Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol 13: 670–676.
[4]
Shea-Donohue T, Fasano A, Smith A, Zhao A (2010) Enteric pathogens and gut function: Role of cytokines and STATs. Gut Microbes 1: 316–324.
[5]
Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D (2010) Gene modulation and immunoregulatory roles of interferon gamma. Cytokine 50: 1–14.
[6]
Averbuch D, Chapgier A, Boisson-Dupuis S, Casanova JL, Engelhard D (2011) The clinical spectrum of patients with deficiency of Signal Transducer and Activator of Transcription-1. Pediatr Infect Dis J 30: 352–355.
[7]
Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, et al. (2003) Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency. Nat Genet 33: 388–391.
[8]
Chapgier A, Wynn RF, Jouanguy E, Filipe-Santos O, Zhang S, et al. (2006) Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol 176: 5078–5083.
Jandu N, Ho NK, Donato KA, Karmali MA, Mascarenhas M, et al. (2009) Enterohemorrhagic Escherichia coli O157:H7 gene expression profiling in response to growth in the presence of host epithelia. PLoS One 4: e4889.
[11]
Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97: 6640–6645.
[12]
Hale L, Lazos O, Haines A, Thomas C (2010) An efficient stress-free strategy to displace stable bacterial plasmids. Biotechniques 48: 223–228.
Rietschel ET, Brade H (1992) Bacterial endotoxins. Sci Am 267: 54–61.
[15]
Rietschel ET, Kirikae T, Schade FU, Ulmer AJ, Holst O, et al. (1993) The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology 187: 169–190.
[16]
David G, Blondeau K, Renouard M, Lewit-Bentley A (2002) Crystallization and preliminary analysis of Escherichia coli YodA. Acta Crystallogr D Biol Crystallogr 58: 1243–1245.
[17]
David G, Blondeau K, Schiltz M, Penel S, Lewit-Bentley A (2003) YodA from Escherichia coli is a metal-binding, lipocalin-like protein. J Biol Chem 278: 43728–43735.
[18]
Ho TD, Davis BM, Ritchie JM, Waldor MK (2008) Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization. Infect Immun 76: 1858–1865.
[19]
Didcock L, Young DF, Goodbourn S, Randall RE (1999) The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73: 9928–9933.
[20]
Nandan D, Reiner NE (1995) Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1. Infect Immun 63: 4495–4500.
[21]
Schmidt MA (2010) LEEways: tales of EPEC, ATEC and EHEC. Cell Microbiol 12: 1544–1552.
[22]
Frankel G, Phillips AD (2008) Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol 10: 549–556.
Dean P, Kenny B (2009) The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol 12: 101–109.
[26]
Castillo A, Eguiarte LE, Souza V (2005) A genomic population genetics analysis of the pathogenic enterocyte effacement island in Escherichia coli: the search for the unit of selection. Proc Natl Acad Sci U S A 102: 1542–1547.
[27]
Muller D, Benz I, Liebchen A, Gallitz I, Karch H, et al. (2009) Comparative analysis of the locus of enterocyte effacement and its flanking regions. Infect Immun 77: 3501–3513.
[28]
Obrig TG (2010) Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) 2: 2769–2794.
[29]
Lingwood CA (1996) Role of verotoxin receptors in pathogenesis. Trends Microbiol 4: 147–153.
[30]
Lathem WW, Grys TE, Witowski SE, Torres AG, Kaper JB, et al. (2002) StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol Microbiol 45: 277–288.
[31]
Brockmeyer J, Bielaszewska M, Fruth A, Bonn ML, Mellmann A, et al. (2007) Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl Environ Microbiol 73: 6351–6359.
[32]
Schmidt H, Karch H, Beutin L (1994) The large-sized plasmids of enterohemorrhagic Escherichia coli O157 strains encode hemolysins which are presumably members of the E. coli alpha-hemolysin family. FEMS Microbiol Lett 117: 189–196.
[33]
Brunder W, Schmidt H, Karch H (1996) KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 142 (Pt 11): 3305–3315.
[34]
Tatsuno I, Horie M, Abe H, Miki T, Makino K, et al. (2001) toxB gene on pO157 of enterohemorrhagic Escherichia coli O157:H7 is required for full epithelial cell adherence phenotype. Infect Immun 69: 6660–6669.
[35]
Lim JY, Yoon J, Hovde CJ (2010) A brief overview of Escherichia coli O157:H7 and its plasmid O157. J Microbiol Biotechnol 20: 5–14.
[36]
Lukjancenko O, Wassenaar TM, Ussery DW (2010) Comparison of 61 sequenced Escherichia coli genomes. Microb Ecol 60: 708–720.
